BDSX
Biodesix Inc
27.70$
+1.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -28.4% | -83.7% | -103.3% | -103.7% | -58.8% | -20.0% | -47.9% | -32.8% | -40.8% | 2.7% | -39.8% | -5.8% | -19.3% | |
| 9.2% | 8.9% | 8.9% | 7.4% | 7.8% | 6.8% | 7.8% | 7.1% | 6.3% | 4.9% | 5.5% | 5.3% | 5.4% | |
| 7.1% | 7.4% | 17.8% | 6.8% | 8.3% | 6.2% | 5.4% | 5.2% | 4.8% | 3.7% | 4.4% | 3.1% | 3.9% | |
| -23.6% | -45.9% | -46.8% | -65.4% | -20.2% | 3.2% | -4.1% | 10.9% | -13.5% | 6.4% | -20.7% | 11.3% | -3.2% | |
| 43.6% | 20.5% | 1.8% | 11.1% | 1.6% | 4.3% | 0.8% | 0.5% | 0.3% | 0.4% | 0.6% | 0.9% | 0.6% | |
| -43.6% | -20.5% | -1.8% | -11.1% | -1.6% | -4.3% | -0.8% | -0.5% | -0.3% | -0.4% | -0.6% | -0.9% | -0.6% | |
| 19.4% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 24.2% | -20.7% | 1.9% | 30.1% | -27.8% | – | 1.7% | – | 2.3% | -1.1% | 1.4% | – | – | |
| – | – | – | – | -0.1% | -0.1% | 0.0% | 49.9% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| 90.1% | 148.1% | 5.3% | 286.3% | 0.8% | -0.9% | 0.5% | 48.9% | 22.2% | 5.9% | 66.1% | 23.2% | 28.8% | |
| 18.0% | 43.9% | -99.8% | 171.4% | -59.6% | -25.3% | -48.1% | 15.6% | -18.9% | 8.3% | 25.8% | 16.5% | 9.0% | |
| -72.1% | -104.2% | -105.2% | -114.9% | -60.4% | -24.4% | -48.7% | -33.3% | -41.1% | 2.3% | -40.4% | -6.8% | -19.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.